| Info Sheets |
| | | | | | | | | | | | | | | | | | | | | | | | |
| Out- side |
| | | | |
|
| | | 'Oral Magnetic Particles' | |
Result : Searchterm 'Oral Magnetic Particles' found in 1 term [] and 3 definitions [], (+ 2 Boolean[] results
| 1 - 5 (of 6) nextResult Pages : [1] [2] | | | | | | |
Oral Magnetic Particles | |
| |
|
Drug Information and Specification NAME OF COMPOUND Barium suspensions, clay mineral particles, iron oxide crystals CENTRAL MOIETY Ba3+, Al3+, Si2+, Fe T2, Predominantly negative enhancement CONCENTRATION Various mixtures DOSAGE Depending on the mixture PREPARATION Depending on the product INDICATION Gastrointestinal bowel marking DEVELOPMENT STAGE No clinical development DO NOT RELY ON THE INFORMATION PROVIDED HERE, THEY ARE NOT A SUBSTITUTE FOR THE ACCOMPANYING PACKAGE INSERT! | | | | | • Share the entry 'Oral Magnetic Particles': | | | | |
| | | | | |
| |
|
This superparamagnetic oral contrast agent consists of large iron oxide particles, coated with insoluble material. Abdoscan® particles have a mean diameter no less than 300 nm. Gastrointestinal superparamagnetic contrast agents are used for negative bowel enhancement.
Abdoscan® was approved in Europe but was taken off the market in 2000, and all sales stopped by the end of 2002.
Drug Information and Specification
T2*, predominantly negative enhancement
PHARMACOKINETIC
Gastrointestinal
CONCENTRATION
23.4 Fe/200ml
DEVELOPMENT STAGE
Not FDA approved
PRESENTATION
Bags with powder
DO NOT RELY ON THE INFORMATION PROVIDED HERE, THEY ARE NOT A SUBSTITUTE FOR THE ACCOMPANYING
PACKAGE INSERT!
| | | | • View the DATABASE results for 'Abdoscan®' (2).
| | | | |
| | | | | |
| |
|
Gastrointestinal (GI) superparamagnetic contrast agents are used in MRI to improve the visualization of e.g., the intestinal tract, the pancreas (see MRCP), etc.
Disadvantages are susceptibility artifacts e.g., dependent on delayed imaging or large volumes resulting in artifacts in the colon and distal small bowel loops related to higher concentration of the particles and absorption of the fluid.
Different types of MRI gastrointestinal superparamagnetic contrast agents:
•
Magnetite albumin microsphere
Usually gastrointestinal superparamagnetic contrast media consist of small iron oxide crystals (ferrites), which produce a signal reduction in the stomach and bowel after oral administration. The T2 shortening caused by these particles is produced from the local magnetic field inhomogeneities associated with the large magnetic moments of superparamagnetic particles. Ferrites are iron oxides of the general formula Fe203.MO, where M is a divalent metal ion and may be mixed with Fe3O4 in different preparations.
Ferrites can produce symptoms of nausea after oral administration, as well as flatulence and a transient rise in serum iron. Embedding in inert substances reduce side effects by decreasing the absorption and interaction with body tissues. Combining these contrast materials with polymers such as polyethylene glycol or cellulose, or with sugars such as dextrose, results in improved T1 and/or T2 relaxivity compared with that of the contrast agent alone.
See also Negative Oral Contrast Agents, Gastrointestinal Diamagnetic Contrast Agents, Relaxivity, and Combination Oral Contrast Agents. | | | | • View the DATABASE results for 'Gastrointestinal Superparamagnetic Contrast Agents' (6).
| | | | Further Reading: | Basics:
|
|
| |
| | | | | |
| |
|
Categories of negative oral contrast agents:
Negative oral contrast media are usually based on superparamagnetic particles and act by inducing local field inhomogeneities, which results in shortening of both T1 and T2 relaxation times. Superparamagnetic contrast agents have predominant T2 weighted effects.
Biphasic contrast media are agents that have different signal intensities on different sequences, depending on the concentration at which they are used.
Suitable materials for oral contrast agents should have little or no absorption by the stomach or intestines, complete excretion, no motion or susceptibility artifacts, affordability, and uniform marking of the gastrointestinal tract.
Benefits of negative oral contrast agents are the reduction of ghosting artifacts caused by the lack of signal. Superparamagnetic iron oxides produce also in low concentrations a noticeable signal loss; but can generate susceptibility artifacts especially in gradient echo sequences. Perfluorochemicals do not dilute in the bowel because they are not miscible with water.
High cost, poor availability, and limited evaluations of side effects are possible disadvantages.
Negative oral contrast agents are used e.g., in MRCP, where the ingestion of 600-900 ml of SPIO cancels out the signal intensity of the lumen (in addition after the injection of a gadolinium-based contrast medium, the enhancement of the inflammatory tissues is clearer seen), and in MR abdominal imaging of Crohn's disease in combination with mannitol.
| | | | • View the DATABASE results for 'Negative Oral Contrast Agents' (7).
| | | | Further Reading: | Basics:
|
|
| |
| | | | | |
| |
|
Diamagnetism occurs only by a substance in the presence of an externally applied magnetic field. Dia magnetic contrast agents are complexes in which the metal ion (e.g., Zn, Bi and Ca) is dia magnetic.
Potential dia magnetic materials in gastrointestinal MRI:
A suspension of clay minerals (Kaopectate with kaolin, a common over the counter drug) can be used as a negative oral contrast agent caused by the dia magnetic properties.
By using this preparation as a gastrointestinal contrast agent e.g., in pancreas MRI or MRCP, the absence of signal is clearly visible in the stomach and duodenum.
Barium sulfate commonly used as an X-ray contrast agent has also been tested for use in abdominal imaging. The dia magnetic properties of the barium particles are caused by a susceptibility effect around them, the resulting signal loss is strengthening by a replacement of water protons with barium.
See also Diamagnetism. | | | | • View the DATABASE results for 'Gastrointestinal Diamagnetic Contrast Agents' (7).
| | | | |
| | | | |
| |
| | 1 - 5 (of 6) nextResult Pages : [1] [2] |
| |
|
| |
| Look Ups |
| |